Navigation Links
Sunesis Pharmaceuticals Presents Nonclinical Data on SNS-595 at the Annual Meeting of the American Association for Cancer Research
Date:4/14/2008

and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Sunesis' current expectations. Forward-looking statements involve risks and uncertainties. Sunesis' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, the risk that Sunesis' drug discovery and development activities, including enrollment and reporting of results, could be halted significantly or delayed for various reasons, the risk that Sunesis' clinical trials for SNS-595 may not demonstrate safety or efficacy or lead to regulatory approval, the risk that preliminary data and trends may not be predictive of future data or results, the risk that Sunesis' preclinical studies and clinical trials may not satisfy the requirements of the FDA or other regulatory agencies, risks related to the conduct of Sunesis' clinical trials and manufacturing of SNS-595 and risks related to Sunesis' need for additional funding. These and other risk factors are discussed under "Risk Factors" and elsewhere in Sunesis' annual report on Form 10-K for the year ended December 31, 2007 and other filings with the Securities and Exchange Commission. Sunesis expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.


'/>"/>
SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Sunesis Pharmaceuticals to Present at Healthcare Investor Conferences in March
2. Sunesis Pharmaceuticals SNS-595 Shows Clinical Activity in Patients With Relapsed or Refractory Acute Leukemias; Data Presented in Oral Session at 49th Annual Meeting of the American Society of Hematology
3. Sunesis Pharmaceuticals Reports New Option Grants Under NASDAQ Marketplace Rule 4350
4. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
5. Alexion Pharmaceuticals Invites You to Participate in its First Quarter 2008 Results Conference Call and Web Cast
6. Access Pharmaceuticals to Present New Data on ProLindac(TM) at the AACR Annual Meeting 2008 Conference
7. ISTA Pharmaceuticals Announces Receipt of Subpoena Relating to Promotional Practices for XIBROM(TM)
8. Aida Pharmaceuticals, Inc. Announces New Antibiotic Drug Under Development
9. Bayer HealthCare Pharmaceuticals, Amerinet Extend Contrast Media Agreement
10. Idenix Pharmaceuticals to Present at the Canaccord Adams Hepatitis C Conference
11. Indevus Pharmaceuticals Licenses European Rights for VANTAS(R) to Orion Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... CA (PRWEB) September 16, 2014 According to ... player David Wilson has retired after aggravating a neck injury ... and was then discovered to have spinal stenosis as well, ... many adults and can lead to symptoms such as back ... play again after surgery to repair the disc, but recently ...
(Date:9/16/2014)... September 16, 2014 According to ... Research "Latin America Home Healthcare Market (By Device ... Devices, Mobility Assist Devices and Medical Supplies; By ... Therapy and Unskilled Home Healthcare Services) - Industry ... - 2020" the Latin American Home Healthcare market ...
(Date:9/16/2014)... 2014 Today The FSH Society, a world ... Evening of Song,” featuring luminary pianist Steven Blier and two-time ... September 29, 2014 at the Tappan Hill Mansion, located on ... FSH Society is proud to welcome Blier, who performs each ... for FSHD research. , FSHD, one of the most prevalent ...
(Date:9/16/2014)... 16, 2014 Luke Sniewski, Claire Robbie ... a 14-month journey around the world to celebrate cultural ... project, titled ‘Million Ways to Live’, will take them ... the healthy lifestyles of amazing, unique and diverse people. ... the documentary series will focus on how individuals apply ...
(Date:9/16/2014)... September 16, 2014 According to a ... global authority in medical device market research, the market ... $750 million in the U.S . and ... PEG placement kits, PEG replacement tubes, DPEJ tubes, PEG/J ... into low-profile balloon tubes, low-profile non-balloon tubes, nasogastric and ...
Breaking Medicine News(10 mins):Health News:NFL Injuries Put Spotlight on Spinal Health 2Health News:NFL Injuries Put Spotlight on Spinal Health 3Health News:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 2Health News:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 3Health News:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 4Health News:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 5Health News:Pianist Steven Blier and Grammy Award-Winner Sylvia McNair to Perform Together for FSH Society Benefit 2Health News:Pianist Steven Blier and Grammy Award-Winner Sylvia McNair to Perform Together for FSH Society Benefit 3Health News:Launched by Luke Sniewski and Claire Robbie, Million Ways to Live is an International Documentary Series on Healthy Living in Different Cultures 2Health News:Launched by Luke Sniewski and Claire Robbie, Million Ways to Live is an International Documentary Series on Healthy Living in Different Cultures 3Health News:Over 17 Million Enteral Feeding Device Placement Procedures is Expected to be Performed in the U.S. and Europe in 2020: Market Led by Covidien, Kimberly-Clark and Abbott 2Health News:Over 17 Million Enteral Feeding Device Placement Procedures is Expected to be Performed in the U.S. and Europe in 2020: Market Led by Covidien, Kimberly-Clark and Abbott 3
... passive smoke could face a higher heart disease risk, says ... second hand smoke exposure through levels of a nicotine by-product ... on the participants' recall of exposure. ,However, in ... of Nottingham, and other researchers measured the level of cotinine ...
... linked to many of the same health problems as tobacco ... wheeze, according to a new study by researchers at Yale ... widely used illicit drug in the United States, and abuse ... published in today’s Archives of Internal Medicine. First author Jeanette ...
... treating atrial fibrillation, a common irregular heart rhythm that ... of Medicine in St. Louis have developed and tested ... surgical procedure that has had the best long-term cure ... procedure is termed Cox-maze IV, and the surgeons believe ...
... migrant birds will be outstaying their welcome in north and central ... has called for tougher measures on bird flu prevention, especially in ... this time, there is an increase in transportation of livestock and ... is predominant during this season. , Yin ...
... that aids patients who suffer from persistent iron overload has ... ,Patients suffering from a rare genetic condition or conditions ... Generally these people are given a painful infusion at nights ... ,But the new drug Exjade is an oral ...
... stress hormone cortisol can have positive effects in certain ... cortisol in the bloodstream, can weaken the immune system ... evidence that cortisol given near in time to a ... impact. ,Psychologists are especially interested in what ...
Cached Medicine News:Health News:Long-term Marijuana Smoking Leads to Respiratory Complaints 2Health News:Surgeons Develop Simpler Way to Cure Atrial Fibrillation 2Health News:Extra Cortisol Protects Women’s Mood Under Stres 2
(Date:9/16/2014)... , Sept. 16, 2014  Synereca Pharmaceutics, ... novel orally active drugs that restore or ... today a $1.4 million convertible debt financing. ... life sciences accelerator Accele Biopharma, Inc., led ... a nationally recognized private not-for-profit corporation focused ...
(Date:9/16/2014)... Alberta , Sept. 16, 2014  Wearable ... billion industry in less than two years, producing ... the way. A huge opportunity exists for leveraging ... Vivametrica ( http://vivametrica.com/our-video/ ) introduced a first-of-its-kind wearable ... based on years of clinical research linking activity ...
(Date:9/16/2014)... , Sept. 16, 2014  Eli Lilly ... AstraZeneca today announced an agreement to co-develop and ... (BACE) inhibitor currently in development as a potential ... of Alzheimer,s disease is characterized by the accumulation ... an enzyme associated with the development of beta-amyloid. ...
Breaking Medicine Technology:Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners 2Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners 3Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners 4Doctors Launch Initiative to Bridge Gap Between Wearables and Meaningful Health Data 2Doctors Launch Initiative to Bridge Gap Between Wearables and Meaningful Health Data 3Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease 2Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease 3Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease 4
... NEW YORK, July 19, 2011 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p0574366/World-Healthcare-UPS-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovascular_Devices This ... healthcare UPS market, examining drivers and restraints ...
... INDIANAPOLIS, July 19, 2011 Data were presented today ... semagacestat, including data from a 32 week follow-up period ... a gamma secretase inhibitor that had been studied as ... provided patient outcomes from the active treatment portion of ...
Cached Medicine Technology:World Healthcare UPS Markets 2World Healthcare UPS Markets 3World Healthcare UPS Markets 4World Healthcare UPS Markets 5World Healthcare UPS Markets 6Lilly Presents Follow-Up Data on Semagacestat to Assist Future Alzheimer's Disease Research 2Lilly Presents Follow-Up Data on Semagacestat to Assist Future Alzheimer's Disease Research 3Lilly Presents Follow-Up Data on Semagacestat to Assist Future Alzheimer's Disease Research 4
Steinmann Pins are available in six point styles ranging from 5/64 to 3/16 in. diameters, in standard 9 in. (230 mm) lengths with threaded and smooth tips. Material: DePuy certified stainless steel. ...
... is the only approved radiolucent stand-alone implant ... with the proven reliability of the BAK ... System is constructed of radiolucent, carbon-fiber reinforced ... radiologic visualization, providing a new level of ...
... (Western Blot): The Genetic Systems HIV-1 Western ... the detection of antibodies to HIV-1. The solid ... HIV-1 grown in the CEM cell line. Use ... of HLA Class ll antigens, helps reduce cross ...
... HIV-1 RNA Assay (bDNA) delivers unmatched precision and ... providing physicians with viral load values they can ... and at other critical decision points - without ... need more reasons to choose VERSANT HIV bDNA, ...
Medicine Products: